Loading…
Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke
Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of str...
Saved in:
Published in: | Acta medica Iranica 2011, Vol.49 (3), p.149-152 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 152 |
container_issue | 3 |
container_start_page | 149 |
container_title | Acta medica Iranica |
container_volume | 49 |
creator | Roudbary, Seyed Ali Saadat, Farshid Forghanparast, Kambiz Sohrabnejad, Reza |
description | Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941</doaj_id><sourcerecordid>872436667</sourcerecordid><originalsourceid>FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3</originalsourceid><addsrcrecordid>eNpdkUtLxTAQhYsoen38BQluXBXybJKlXHxcEFyo6zJJJ5pr22jaCv57g6-FqxkOH4dzZnaqFdNC1baxcrdaUSpl3VCuDqrDadpSKgxner864KwxTFO2qvAe8zKQdZ0R_BzfkbzmNGMcSY_v2BOYCBAX0wD5BTMJKZMuhoAZxznCHNNIUiBx8s84RE9CTgMpa8r5GZ6KMM05veBxtRegn_DkZx5Vj1eXD-ub-vbuerO-uK07zsxcdxQd-sDRBKNUxy0KEEAZsMZqBtwK5ShqAUY7ROkVOt15BcEIT6Vx4qjafPt2Cbbta44l9kebILZfQspPLeQ5-h5bKS04ywxD20juwCmkQgdpPVfeSla8zr-9ykHeFpzmdig1se9hxLRMrdFciqZpdCHP_pHbtOSxFC2QMEpyYwt0-gMtbsDuL9zvK8Qnx8CGZg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>873854289</pqid></control><display><type>article</type><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</creator><creatorcontrib>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</creatorcontrib><description>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P<0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</description><identifier>ISSN: 0044-6025</identifier><identifier>EISSN: 1735-9694</identifier><identifier>PMID: 21681701</identifier><language>eng</language><publisher>Iran: Tehran University of Medical Sciences</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers - blood ; Brain Ischemia - blood ; Brain Ischemia - complications ; Brain Ischemia - diagnosis ; C-Reactive Protein - analysis ; Cerebrovascuar Accidents ; Diagnosis, Differential ; Female ; Hemorrhagic Stroke ; High Sensitive C-reactive Protein (hs-CRP) ; Humans ; Intracranial Hemorrhages - blood ; Intracranial Hemorrhages - complications ; Intracranial Hemorrhages - diagnosis ; Ischemic Stroke ; Male ; Middle Aged ; Stroke - etiology</subject><ispartof>Acta medica Iranica, 2011, Vol.49 (3), p.149-152</ispartof><rights>Copyright Dr Ali Akbari Sari, Director of The Commission for Accreditation & Improvement of Iranian Medical Journals 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/873854289/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/873854289?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,4024,25753,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21681701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roudbary, Seyed Ali</creatorcontrib><creatorcontrib>Saadat, Farshid</creatorcontrib><creatorcontrib>Forghanparast, Kambiz</creatorcontrib><creatorcontrib>Sohrabnejad, Reza</creatorcontrib><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><title>Acta medica Iranica</title><addtitle>Acta Med Iran</addtitle><description>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P<0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - blood</subject><subject>Brain Ischemia - blood</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - diagnosis</subject><subject>C-Reactive Protein - analysis</subject><subject>Cerebrovascuar Accidents</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Hemorrhagic Stroke</subject><subject>High Sensitive C-reactive Protein (hs-CRP)</subject><subject>Humans</subject><subject>Intracranial Hemorrhages - blood</subject><subject>Intracranial Hemorrhages - complications</subject><subject>Intracranial Hemorrhages - diagnosis</subject><subject>Ischemic Stroke</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Stroke - etiology</subject><issn>0044-6025</issn><issn>1735-9694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkUtLxTAQhYsoen38BQluXBXybJKlXHxcEFyo6zJJJ5pr22jaCv57g6-FqxkOH4dzZnaqFdNC1baxcrdaUSpl3VCuDqrDadpSKgxner864KwxTFO2qvAe8zKQdZ0R_BzfkbzmNGMcSY_v2BOYCBAX0wD5BTMJKZMuhoAZxznCHNNIUiBx8s84RE9CTgMpa8r5GZ6KMM05veBxtRegn_DkZx5Vj1eXD-ub-vbuerO-uK07zsxcdxQd-sDRBKNUxy0KEEAZsMZqBtwK5ShqAUY7ROkVOt15BcEIT6Vx4qjafPt2Cbbta44l9kebILZfQspPLeQ5-h5bKS04ywxD20juwCmkQgdpPVfeSla8zr-9ykHeFpzmdig1se9hxLRMrdFciqZpdCHP_pHbtOSxFC2QMEpyYwt0-gMtbsDuL9zvK8Qnx8CGZg</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Roudbary, Seyed Ali</creator><creator>Saadat, Farshid</creator><creator>Forghanparast, Kambiz</creator><creator>Sohrabnejad, Reza</creator><general>Tehran University of Medical Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2011</creationdate><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><author>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - blood</topic><topic>Brain Ischemia - blood</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - diagnosis</topic><topic>C-Reactive Protein - analysis</topic><topic>Cerebrovascuar Accidents</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Hemorrhagic Stroke</topic><topic>High Sensitive C-reactive Protein (hs-CRP)</topic><topic>Humans</topic><topic>Intracranial Hemorrhages - blood</topic><topic>Intracranial Hemorrhages - complications</topic><topic>Intracranial Hemorrhages - diagnosis</topic><topic>Ischemic Stroke</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Stroke - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roudbary, Seyed Ali</creatorcontrib><creatorcontrib>Saadat, Farshid</creatorcontrib><creatorcontrib>Forghanparast, Kambiz</creatorcontrib><creatorcontrib>Sohrabnejad, Reza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Acta medica Iranica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roudbary, Seyed Ali</au><au>Saadat, Farshid</au><au>Forghanparast, Kambiz</au><au>Sohrabnejad, Reza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</atitle><jtitle>Acta medica Iranica</jtitle><addtitle>Acta Med Iran</addtitle><date>2011</date><risdate>2011</risdate><volume>49</volume><issue>3</issue><spage>149</spage><epage>152</epage><pages>149-152</pages><issn>0044-6025</issn><eissn>1735-9694</eissn><abstract>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P<0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</abstract><cop>Iran</cop><pub>Tehran University of Medical Sciences</pub><pmid>21681701</pmid><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0044-6025 |
ispartof | Acta medica Iranica, 2011, Vol.49 (3), p.149-152 |
issn | 0044-6025 1735-9694 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | Aged Aged, 80 and over Biomarkers - blood Brain Ischemia - blood Brain Ischemia - complications Brain Ischemia - diagnosis C-Reactive Protein - analysis Cerebrovascuar Accidents Diagnosis, Differential Female Hemorrhagic Stroke High Sensitive C-reactive Protein (hs-CRP) Humans Intracranial Hemorrhages - blood Intracranial Hemorrhages - complications Intracranial Hemorrhages - diagnosis Ischemic Stroke Male Middle Aged Stroke - etiology |
title | Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20C-reactive%20protein%20level%20as%20a%20biomarker%20for%20differentiation%20of%20ischemic%20from%20hemorrhagic%20stroke&rft.jtitle=Acta%20medica%20Iranica&rft.au=Roudbary,%20Seyed%20Ali&rft.date=2011&rft.volume=49&rft.issue=3&rft.spage=149&rft.epage=152&rft.pages=149-152&rft.issn=0044-6025&rft.eissn=1735-9694&rft_id=info:doi/&rft_dat=%3Cproquest_doaj_%3E872436667%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=873854289&rft_id=info:pmid/21681701&rfr_iscdi=true |